ARMON IMBRIGLIO: Open Payments
NPI 1497780928 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 30 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $661 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $294 |
| Novo Nordisk Inc | 5 | $198 |
| GlaxoSmithKline, LLC. | 5 | $110 |
| Exact Sciences Corporation | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
Products named: BREZTRI, Wegovy, TRELEGY ELLIPTA, Cologuard Collection Kit, FARXIGA, AIRSUPRA, Ozempic, JARDIANCE.
Industry payments across NY — which companies pay providers there.
